382 related articles for article (PubMed ID: 3002452)
1. Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients.
Chace KV; Flux M; Sachdev GP
Biochemistry; 1985 Dec; 24(25):7334-41. PubMed ID: 3002452
[TBL] [Abstract][Full Text] [Related]
2. Physical properties of purified human respiratory mucus glycoproteins: effects of sodium chloride concentration on the aggregation properties and shape.
Chace KV; Naziruddin B; Desai VC; Flux M; Sachdev GP
Exp Lung Res; 1989 Sep; 15(5):721-37. PubMed ID: 2806194
[TBL] [Abstract][Full Text] [Related]
3. Macromolecular properties and polymeric structure of canine tracheal mucins.
Shankar V; Virmani AK; Naziruddin B; Sachdev GP
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):525-32. PubMed ID: 2049078
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
Kirkham S; Sheehan JK; Knight D; Richardson PS; Thornton DJ
Biochem J; 2002 Feb; 361(Pt 3):537-46. PubMed ID: 11802783
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of a minor mucin component from cystic fibrosis tracheobronchial secretions.
Padhye NV; Naziruddin B; Desai VC; Reyes de la Rocha S; Sachdev GP
Biochim Biophys Acta; 1991 Apr; 1077(3):332-8. PubMed ID: 2029532
[TBL] [Abstract][Full Text] [Related]
6. Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals.
Rose MC; Brown CF; Jacoby JZ; Lynn WS; Kaufman B
Pediatr Res; 1987 Nov; 22(5):545-51. PubMed ID: 3684381
[TBL] [Abstract][Full Text] [Related]
7. Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture'.
Thornton DJ; Sheehan JK; Lindgren H; Carlstedt I
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):667-75. PubMed ID: 2064605
[TBL] [Abstract][Full Text] [Related]
8. Biophysical characterization of mucin components HTM-1 and HTM-2 from tracheobronchial secretions of cystic fibrosis patients.
Padhye NV; Shankar V; Reyes de la Rocha S; Sachdev GP
Biochim Biophys Acta; 1994 Nov; 1209(1):56-60. PubMed ID: 7947982
[TBL] [Abstract][Full Text] [Related]
9. Polymeric structure of human respiratory mucin: studies on two protein components released upon reduction of disulfide bonds.
Naziruddin B; Shankar V; Reyes de la Rocha S; Sachdev GP
Biochim Biophys Acta; 1990 Nov; 1041(2):164-71. PubMed ID: 2265202
[TBL] [Abstract][Full Text] [Related]
10. Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients.
Khatri IA; Bhaskar KR; Lamont JT; Sajjan SU; Ho CK; Forstner J
Pediatr Res; 2003 Apr; 53(4):619-27. PubMed ID: 12612214
[TBL] [Abstract][Full Text] [Related]
11. The structure of tracheobronchial mucins from cystic fibrosis and control patients.
Gupta R; Jentoft N
J Biol Chem; 1992 Feb; 267(5):3160-7. PubMed ID: 1737770
[TBL] [Abstract][Full Text] [Related]
12. Evidence of hydrophobic domains in human respiratory mucins. Effect of sodium chloride on hydrophobic binding properties.
Shankar V; Naziruddin B; Reyes de la Rocha S; Sachdev GP
Biochemistry; 1990 Jun; 29(24):5856-64. PubMed ID: 2383563
[TBL] [Abstract][Full Text] [Related]
13. Peptide mapping reveals differences in the non-glycosylated domains of cystic fibrosis and normal tracheobronchial mucins.
Desai VC; Shankar V; de la Rocha SR; Sachdev GP
Indian J Biochem Biophys; 1993 Dec; 30(6):382-8. PubMed ID: 8005622
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the in vivo degradation of human respiratory mucins during Pseudomonas aeruginosa infection.
Houdret N; Ramphal R; Scharfman A; Perini JM; Filliat M; Lamblin G; Roussel P
Biochim Biophys Acta; 1989 Jul; 992(1):96-105. PubMed ID: 2752044
[TBL] [Abstract][Full Text] [Related]
15. Isolation of bronchial mucins from cystic fibrosis sputum by use of citraconic anhydride.
Snyder CE; Nadziejko CE; Herp A
Carbohydr Res; 1982 Jul; 105(1):87-93. PubMed ID: 7116358
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and rheological characterization of sputum mucins from a patient with cystic fibrosis.
Tabachnik NF; Blackburn P; Cerami A
J Biol Chem; 1981 Jul; 256(14):7161-5. PubMed ID: 7251591
[TBL] [Abstract][Full Text] [Related]
17. Mucins, mucus, and sputum.
Voynow JA; Rubin BK
Chest; 2009 Feb; 135(2):505-512. PubMed ID: 19201713
[TBL] [Abstract][Full Text] [Related]
18. Complex structure of human bronchial mucus glycoprotein.
Slayter HS; Lamblin G; Le Treut A; Galabert C; Houdret N; Degand P; Roussel P
Eur J Biochem; 1984 Jul; 142(2):209-18. PubMed ID: 6745272
[TBL] [Abstract][Full Text] [Related]
19. Neutral and acidic human tracheobronchial mucin. Isolation and characterization of core protein.
Bhattacharyya SN; Veit BC; Manna B; Enriquez JI; Walker MP; Khorrami AM; Kaufman B
Inflammation; 1990 Aug; 14(4):355-73. PubMed ID: 2379952
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.
Henderson AG; Ehre C; Button B; Abdullah LH; Cai LH; Leigh MW; DeMaria GC; Matsui H; Donaldson SH; Davis CW; Sheehan JK; Boucher RC; Kesimer M
J Clin Invest; 2014 Jul; 124(7):3047-60. PubMed ID: 24892808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
